Biology Reference
In-Depth Information
157. Brusniak MY, Kwok ST, Christiansen M, et al.
ATAQS: A computational software tool for high
throughput transition optimization and validation for
selected reaction monitoring mass spectrometry.
BMC
Bioinformatics
2011;
170. Yoon Joo Y, Yeom J, Lee H, et al. High-throughput
peptide quanti
cation using mTRAQ reagent triplex.
BMC Bioinformatics
2011;
(Suppl. 1):S46.
171. DeSouza LV, Krakovska O, Dar
12
er MM, et al.
:78.
158. Reiter L, Rinner O, Picotti P, et al. mProphet: automated
data processing and statistical validation for large-scale
SRM experiments.
Nat Methods
2011;
mTRAQ-based quanti
cation of potential endometrial
carcinoma biomarkers from archived formalin-
12
xed
:3108
e
16.
172. Proc JL, Kuzyk MA, Hardie DB, et al. A quantitative
study of the effects of chaotropic agents, surfactants,
and solvents on the digestion ef
paraf
n-embedded tissues.
Proteomics
2010;
10
:430
e
5.
159. Sherman J, McKay MJ, Ashman K, et al. Unique ion
signature mass spectrometry, a deterministic method
to assign peptide identity.
Mol Cell Proteomics
2009;
8
ciency of human
plasma proteins by trypsin.
J Proteome Res
2010;
:
:
8
9
2051
e
62.
5422
e
37.
173. Speers AE, Wu CC. Proteomics of integral membrane
proteins
d
theory and application.
Chem Rev
2007;
160.
Jaffe JD, Keshishian H, Chang B, et al. Accurate
inclusion mass screening: a bridge from unbiased
discovery
:
107
to
targeted assay development
for
3687
e
714.
174. Beynon RJ, Doherty MK, Pratt JM, et al. Multiplexed
absolute quanti
biomarker veri
cation.
Mol Cell Proteomics
2008;
7
:
1952
e
62.
161. Lange V, Malmstrom JA, Didion J, et al. Targeted
quantitative analysis of Streptococcus pyogenes viru-
lence factors by multiple reaction monitoring.
Mol Cell
Proteomics
2008;
cial
QCAT proteins of concatenated signature peptides.
Nat Methods
2005;
cation in proteomics using arti
:587
e
9.
175. Swainston N, Jameson D, Carroll K. A QconCAT
informatics pipeline for the analysis, visualization and
sharing of absolute quantitative proteomics data.
Proteomics
2011;
2
:1489
e
500.
162. Sabido E, Selevsek N, Aebersold R. Mass spectrometry-
based proteomics for systems biology.
Curr Opin Bio-
technol
2011;
7
:329
e
33.
176. Andrews GL, Simons BL, Young JB, et al. Performance
characteristics of a new hybrid quadrupole time-of-
11
:591
e
7.
163. Deutsch EW, Chambers M, Neumann S, et al.
TraML
d
a standard format for exchange of selected
reaction monitoring transition lists.
Mol Cell Proteomics
2012;
23
flight tandem mass spectrometer (TripleTOF 5600).
Anal Chem
2011;
:5442
e
6.
177. Zhou L, Zhao SZ, Koh SK, et al. In-depth analysis of
the human tear proteome.
83
:R111.015040.
164. Keshishian H, Addona T, Burgess M, et al. Quantita-
tive, multiplexed assays for low abundance proteins in
plasma by targeted mass spectrometry and stable
isotope dilution.
Mol Cell Proteomics
2007;
11
J Proteomics
2012;
:
75
3877
e
85.
178. Gillet LC, Navarro P, Tate S, et al. Targeted data
extraction of the MS/MS spectra generated by data-
independent acquisition: a new concept for consistent
and accurate proteome analysis.
Mol Cell Proteomics
2012;
:2212
e
29.
165. Gerber SA, Rush J, Stemman O, et al. Absolute
quanti
6
cation of proteins and phosphoproteins from
cell lysates by tandem MS.
Proc Natl Acad Sci USA
2003;
:O111.016717.
179. Ramos AA, Yang H, Rosen LE, et al. Tandem parallel
fragmentation of peptides for mass spectrometry.
Anal
Chem
2006;
11
:6940
e
5.
166. Kuhn E, Whiteaker JR, Mani DR, et al. Interlaboratory
evaluation of automated, multiplexed peptide immu-
noaf
100
:6391
e
7.
180. Geromanos SJ, Vissers JPC, Silva JC, et al. The detec-
tion, correlation, and comparison of peptide precursor
and product ions from data independent LC-MS with
data dependent LC-MS/MS.
Proteomics
78
nity enrichment coupled to multiple reaction
monitoring mass spectrometry for quantifying
proteins in plasma.
Mol Cell Proteomics
2012;
:M111.
11
013854.
167. Keshishian H, Addona T, Burgess M, et al. Quantifi-
2009;
9
:
-
cation of cardiovascular biomarkers in patient plasma
by targeted mass spectrometry and stable isotope
dilution.
Mol Cell Proteomics
2009;
1683
e
95.
181. Geiger T, Cox J, Mann M. Proteomics on an Orbitrap
benchtop mass spectrometer using all-ion fragmenta-
tion.
Mol Cell Proteomics
2010;
:2339
e
49.
168. Carr SA, Anderson L. Protein quantitation through
targeted mass spectrometry: the way out of biomarker
purgatory?
Clin Chem
2008;
8
:2252
e
61.
182. Blackburn K, Mbeunkui F, Mitra SK, et al. Impro-
ving protein and proteome coverage through data-
independent multiplexed
9
:1749
e
52.
169. Bajrami B, Farrokhi V, Zhang M, et al. Back to
deuterium: Utility of
2
H-labeled peptides for targeted
quantitative proteomics.
Int J Mass Spectrom
2012;
54
peptide
fragmentation.
:3621
e
37.
183. Anderson NL. The clinical plasma proteome: a survey
of clinical assays for proteins in plasma and serum.
Clin Chem
2010;
J Proteome Res
2010;
9
312
:
17
e
23.
:177
e
85.
56
Search WWH ::
Custom Search